期刊文献+

前列腺特异性抗原灰区的前列腺癌临床资料分析 被引量:9

Clinical analysis of prostate cancer in PSA grey zone
原文传递
导出
摘要 目的分析前列腺特异性抗原(PSA)灰区(4~10 ng/ml)与前列腺癌的关系,探索如何提高灰区PSA水平的前列腺癌活检诊断率。方法对2004年3月至2005年3月间,PSA介于灰区、接受前列腺穿刺活检的72例病人资料进行回顾分析。包括肛指检查、IPSS评分、经直肠超声(TRUS)检查、PSA密度(PSAD)、游离/总PSA(F/T)比值以及病理学酶标检查。结果穿刺组织病理学检查证实为前列腺癌14例(19.2%),平均年龄(74.2±2.4)岁,IPSS(12.9±4.5),PSAD(0.29±0.04),F/T(0.11±0.02)。GS评分≤6共9例,GS=7共2例,GS≥8共3例。肛指有结节3例,无结节11例。TRUS低回声区2例,等回声区2例,回声不均6例,回声均匀4例。前列腺尖部穿刺阳性率占51.4%。结论PSAD和F/T在PSA灰区的前列腺癌和前列腺增生两组间有明显差别;PSA灰区范围内,前列腺尖部是前列腺癌的高发部位。 Objective To analyze the clinical data of prostate cancer whose PSA was in grey zone (4-10 ng/ml). Methods From Mar.2004 to Mar 2005, 72 patients whose PSA Level lied between 4-10 ng/ml were enrolled in this study, several items including digital rectal examination, IPSS, TRUS, PSAD, FIT and pathological enzymatic examination were analyzed. Results 14 patients (19.2%) were diagnosed as prostate cancer with the proof of pathological results. Mean age (74.2±2.4), IPSS(12.9±4.5), PSAD(0.29±0.04), F/T(0.11±0.02). 9 cases with Gleason score less than 6,2 cases equal to 7 and 3 cases more than 8. Three cases had prostate nodule by DRE, and 2 cases had lower resonance in TRUS, 2 cases with equal resonance, 6 cases with irregular resonance during TRUS. Prostate apex was thought as the most common location for cancer. Conclusion PSAD and FIT might be the surrogate marker for prostate cancer in grey zone compared with other items, the most possible lesion for prostate cancer is apex.
出处 《中国男科学杂志》 CAS CSCD 2007年第11期33-35,共3页 Chinese Journal of Andrology
关键词 前列腺肿瘤 PSA灰区 诊断 prostatic neoplasms grey zone diagnosis
  • 相关文献

参考文献6

二级参考文献17

  • 1Altman AL,Resnick MC.Ultrasonographically guided biopsy of the prostate gland.J Ultrasound Med,2001,20:159-167.
  • 2Borboroglu PG,Comer SW,Riffenburgh RH,et al.Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.J Urol,2000,163:158-162.
  • 3Stewart CS,Leibovich BC,Weaver AL,et al.Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.J Urol,2001,166:86-92.
  • 4Main BM,Naya Y,Okihara K,et al.Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.Urology,2002,60:836-840.
  • 5Hodge KK,McNeal JE,Terris MK,et al.Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.J Urol,1989,142:71-74.
  • 6Rabbani F,Stroumbakis N,Kava BR,et al.Incidence and clinical significance of false-negative sextant prostate biopsies.J Urol,1998,159:1247-1250.
  • 7Ukimura O,Durrani O,Babaian BJ.Role of PSA and its indices in determining the need for repeat prostate biopsies.Urology,1997,50:66-72.
  • 8Vashi AR,Wojno KJ,Gillespie B,et al.A model for the number of cores per prostate biopsy based on patient age and prostate gland volume.J Urol,1998,159:920-924.
  • 9Levine MA,Ittman M,Melamed J,et al.Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.J Urol,1998,159:471-475.
  • 10O'Dowd GJ,Miller MC,Orozco R,et al.Analysis of repeated biopsy results within 1 year after a noncancer diagnosis.Urology,2000,55:553-559.

共引文献102

同被引文献84

  • 1孟小鑫,华立新,吴宏飞.经直肠前列腺穿刺活检并发症分析[J].中华男科学杂志,2002,8(3):210-211. 被引量:14
  • 2李贵忠,刘流,黄广林,陈涛,闫冰,高岩,罗飞,刘宁,王建伟,满立波,何峰,王海.经会阴B型超声引导下前列腺穿刺活检的临床价值研究[J].中华男科学杂志,2005,11(11):828-831. 被引量:8
  • 3朱生才,刘明,王建业.血清前列腺特异抗原4~10μg/L的前列腺癌“灰区”的诊断和治疗[J].中华老年医学杂志,2006,25(4):269-271. 被引量:10
  • 4迟流萤,赵鑫,杨希秀,毛红宇.前列腺增生及前列腺癌患者f-PSA/T-PSA的变化[J].放射免疫学杂志,2007,20(2):169-171. 被引量:2
  • 5Morote J,Raventos CX,Lorente JA,et al.Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specifc antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng/ml[J].J Urol,1997,158:502.
  • 6Lujan M,Paez A,Lanes L,et al.Proste specific antigen density is there a role for this parameter when screening for prostate cancer[J].Prostate Cancer and Prostatic Diseases,2001,4:146-149.
  • 7Kapoor N,Jain R,Surange S,et al.Prostate specific antigen ratio:for diagnosis and assessment of aggressiveness of malignancy of prostate[J].Indian J Pathol Microbiol,2006,49:178-181.
  • 8ORNSTEIN D K,RAYFORD W,FUSARO V A,et al.Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml[J].J Urol,2004,172(4 Pt 1):1302-1305.
  • 9SHEIKH M,AL-SAEED O,KEHINDE E O,et al.Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men[J].Int Urol Nephrol,2005,37(4):721-726.
  • 10OESTERLING J E,TEKCHANDANI A H,MARTIN S K,et al.The periurethral glands do not significantly influence the serum prostate specific antigen concentration[J].J Urol,1996,155(5):1658-1660.

引证文献9

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部